DK2804611T3 - Chitosanafledte forbindelser - Google Patents

Chitosanafledte forbindelser Download PDF

Info

Publication number
DK2804611T3
DK2804611T3 DK13738505.0T DK13738505T DK2804611T3 DK 2804611 T3 DK2804611 T3 DK 2804611T3 DK 13738505 T DK13738505 T DK 13738505T DK 2804611 T3 DK2804611 T3 DK 2804611T3
Authority
DK
Denmark
Prior art keywords
chitosane
derived compounds
derived
compounds
Prior art date
Application number
DK13738505.0T
Other languages
English (en)
Inventor
Tomas Hode
Robert E Nordquist
Wei R Chen
Raoul Carubelli
Luciano Alleruzzo
Peter Jenkins
Kristopher Waynant
Joseph Raker
Original Assignee
Immunophotonics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48799808&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2804611(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Immunophotonics Inc filed Critical Immunophotonics Inc
Application granted granted Critical
Publication of DK2804611T3 publication Critical patent/DK2804611T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6807—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Polymers & Plastics (AREA)
  • Otolaryngology (AREA)
  • Optics & Photonics (AREA)
  • Oncology (AREA)
  • Medical Informatics (AREA)
  • Materials Engineering (AREA)
  • Electromagnetism (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK13738505.0T 2012-01-20 2013-01-17 Chitosanafledte forbindelser DK2804611T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261588783P 2012-01-20 2012-01-20
PCT/US2013/021903 WO2013109732A2 (en) 2012-01-20 2013-01-17 Chitosan-derived compositions

Publications (1)

Publication Number Publication Date
DK2804611T3 true DK2804611T3 (da) 2020-11-09

Family

ID=48799808

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13738505.0T DK2804611T3 (da) 2012-01-20 2013-01-17 Chitosanafledte forbindelser

Country Status (31)

Country Link
US (1) US20150018748A1 (da)
EP (2) EP3831393A1 (da)
JP (1) JP6180436B2 (da)
KR (5) KR20200139254A (da)
CN (2) CN104619310A (da)
AU (1) AU2013209716B2 (da)
BR (1) BR112014017426B1 (da)
CA (1) CA2861367C (da)
CL (1) CL2014001880A1 (da)
CO (1) CO7101239A2 (da)
CY (1) CY1123490T1 (da)
DK (1) DK2804611T3 (da)
EA (1) EA030148B1 (da)
EC (1) ECSP14014778A (da)
ES (1) ES2829899T3 (da)
HK (1) HK1210019A1 (da)
HR (1) HRP20201647T1 (da)
HU (1) HUE051744T2 (da)
IL (1) IL233649B (da)
LT (1) LT2804611T (da)
MX (1) MX371275B (da)
MY (1) MY191932A (da)
NZ (1) NZ628433A (da)
PE (1) PE20142325A1 (da)
PL (1) PL2804611T3 (da)
PT (1) PT2804611T (da)
RS (1) RS61257B1 (da)
SG (1) SG11201403943TA (da)
SI (1) SI2804611T1 (da)
SM (1) SMT202000637T1 (da)
WO (1) WO2013109732A2 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11773188B2 (en) 2012-01-20 2023-10-03 Immunophotonics, Inc Chitosan-derived compositions
US11111316B2 (en) * 2012-01-20 2021-09-07 Immunophotonics, Inc. Chitosan-derived compositions
US9259357B2 (en) 2014-04-16 2016-02-16 Loma Linda University Composition, preparation, and use of chitosan shards for biomedical applications
CN107200788B (zh) * 2017-05-11 2020-04-14 暨南大学 一种季鏻化壳聚糖及其作为疫苗免疫佐剂的应用
US20200010575A1 (en) * 2018-07-05 2020-01-09 Immunophotonics, Inc. Semi-synthetic biopolymers for use in treating proliferative disorders
WO2020060131A1 (ko) * 2018-09-19 2020-03-26 주식회사 엘지화학 LiOH를 포함하는 리튬 이차 전지용 전극, 그의 제조방법, 및 상기 전극을 포함하는 리튬 이차 전지
UA128431C2 (uk) 2018-11-26 2024-07-10 Форті Севен, Інк. ГУМАНІЗОВАНЕ АНТИТІЛО ДО c-Kit
BR112021021699A8 (pt) 2019-05-02 2023-04-25 Stimit Corp Tratamento de câncer
GB202007703D0 (en) * 2020-05-22 2020-07-08 Nanomerics Ltd Amphiphilic carbohydrate compounds
WO2023028311A1 (en) * 2021-08-27 2023-03-02 Immunophotonics, Inc. Glycated chitosans for treatment of viral infections
KR20240118747A (ko) * 2021-09-21 2024-08-05 임무노포토닉스 인코퍼레이티드 당화 키토산을 제조하기 위한 방법
AU2023413685A1 (en) 2022-12-20 2025-06-19 Lytix Biopharma As Compositions comprising an oncolytic peptide and chitosan
EP4637799A1 (en) 2022-12-20 2025-10-29 Lytix Biopharma AS Medical products containing an aqueous formulation of a peptide
CN117820043A (zh) * 2023-03-21 2024-04-05 广州优卡思农业技术有限公司 一种龙虾壳水溶性肥料及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US591200A (en) 1897-10-05 Safe-lock
US4424346A (en) * 1981-06-04 1984-01-03 Canadian Patents And Development Ltd. Derivatives of chitins, chitosans and other polysaccharides
US5095030A (en) 1987-01-20 1992-03-10 University Of British Columbia Wavelength-specific cytotoxic agents
US5002962A (en) 1988-07-20 1991-03-26 Health Research, Inc. Photosensitizing agents
US5214036A (en) 1990-03-08 1993-05-25 University Of British Columbia Benzoporphyrin derivatives for photodynamic therapy
US5258453A (en) 1992-01-21 1993-11-02 University Of Utah Drug delivery system for the simultaneous delivery of drugs activatable by enzymes and light
US5283225A (en) 1992-11-24 1994-02-01 Eastman Kodak Company Underlayer of dye-donor element for thermal dye transfer systems
US5912000A (en) * 1994-09-23 1999-06-15 Zonagen, Inc. Chitosan induced immunopotentiation
WO1996031237A2 (en) * 1995-04-04 1996-10-10 Wound Healing Of Oklahoma Cancer treatment by photodynamic therapy, in combination with an immunoadjuvant
US6316007B1 (en) * 1995-04-04 2001-11-13 Wound Healing Of Oklahoma Combined physical and immunotherapy for cancer
TW389694B (en) * 1995-08-17 2000-05-11 Novartis Ag Compositions including o-carboxyalkyl chitosan and methods of use in ophthalmics
JP4606586B2 (ja) 1998-11-10 2011-01-05 株式会社ネーテック 機能性キトサン誘導体
US20020022032A1 (en) * 1999-04-23 2002-02-21 Curry Patrick Mark Immuno-adjuvant PDT treatment of metastatic tumors
US20040047892A1 (en) * 2000-11-15 2004-03-11 Desrosiers Eric Andre Filler composition for soft tissue augmentation and reconstructive surgery
US6756363B1 (en) * 2000-11-17 2004-06-29 Wound Healing Of Oklahoma, Inc. Solutions and films of glycated chitosan
RU2501811C2 (ru) * 2007-11-13 2013-12-20 Био-Текнолоджи Дженерал (Изрейел) Лтд. Способ стерилизации посредством фильтрации разбавленных вязкоэластичных биополимеров (варианты)
CN101440136B (zh) * 2008-12-12 2011-07-06 中国海洋大学 胺糖化几丁聚糖复合物的制备方法

Also Published As

Publication number Publication date
IL233649B (en) 2019-07-31
JP6180436B2 (ja) 2017-08-16
ECSP14014778A (es) 2016-01-29
SI2804611T1 (sl) 2021-01-29
WO2013109732A2 (en) 2013-07-25
WO2013109732A3 (en) 2015-01-08
EP2804611A2 (en) 2014-11-26
EP3831393A1 (en) 2021-06-09
LT2804611T (lt) 2020-11-25
HK1210019A1 (en) 2016-04-15
KR20140117487A (ko) 2014-10-07
KR20170032490A (ko) 2017-03-22
HUE051744T2 (hu) 2021-03-29
CA2861367A1 (en) 2013-07-25
CO7101239A2 (es) 2014-10-31
CA2861367C (en) 2021-06-29
KR20200139254A (ko) 2020-12-11
MX2014008702A (es) 2015-04-08
RS61257B1 (sr) 2021-01-29
EP2804611B1 (en) 2020-09-30
SG11201403943TA (en) 2014-08-28
CN104619310A (zh) 2015-05-13
MX371275B (es) 2020-01-23
IL233649A0 (en) 2014-08-31
NZ628433A (en) 2017-02-24
PE20142325A1 (es) 2015-02-01
AU2013209716A1 (en) 2014-08-28
KR20180123727A (ko) 2018-11-19
BR112014017426B1 (pt) 2021-12-28
MY191932A (en) 2022-07-19
CN110038125A (zh) 2019-07-23
PL2804611T3 (pl) 2021-03-08
EA201491402A1 (ru) 2014-12-30
PT2804611T (pt) 2020-11-12
BR112014017426A2 (pt) 2017-06-13
AU2013209716B2 (en) 2017-04-27
SMT202000637T1 (it) 2021-01-05
EA030148B1 (ru) 2018-06-29
CY1123490T1 (el) 2022-03-24
CL2014001880A1 (es) 2014-11-07
US20150018748A1 (en) 2015-01-15
BR112014017426A8 (pt) 2017-07-04
EP2804611A4 (en) 2016-02-17
HRP20201647T1 (hr) 2021-06-25
JP2015513522A (ja) 2015-05-14
ES2829899T3 (es) 2021-06-02
KR20220028153A (ko) 2022-03-08

Similar Documents

Publication Publication Date Title
NL301130I2 (nl) Remimazolam
HRP20171005T1 (hr) Spojevi imidazopirolidinona
EP2763896A4 (en) UNMANUFACTURED AIRCRAFT WITH SEVERAL ROTORS
DK2859055T3 (da) Polymercoatings
EP2880683A4 (en) BVA INTERPOSER
DK2825087T3 (da) Otoscanner
DK2839013T3 (da) Ikke-disruptiv-gen-targetering
EP2809145A4 (en) CHLOROPLAST TRANSIT PEPTIDES
EP2847405A4 (en) DOOR CLOSURE SYSTEM
EP2814472A4 (en) DITHIOAMINE REDUCING AGENTS
EP2824794A4 (en) Charging cable
HRP20170226T1 (hr) Spoj pirazinkarboksamida
EP2805877A4 (en) UNDER HOOD
DK2873977T3 (da) Dobbeltdækker-rørdispenser
DE112012006109A5 (de) Okklusionsschienenanordnung
PT3068786T (pt) Compostos de pirazolopirimidina
CO6990736A2 (es) Pirrolidina-2-carboxamidas sustituídas
DK2854722T3 (da) Stomipose
EP2941099A4 (en) SWITCHING DEVICE
EP2831482A4 (en) Flange gasket
IL239447A0 (en) Novel compounds
EP2816694A4 (en) FLAT CABLE WINDING DEVICE
DK2825157T3 (da) Aminosyrelipider
EP2809729A4 (en) Siloxane polyether copolymers
EP2869113A4 (en) GAHRZEUGANZEIGEVORRICHTUNG